Wyeth says court rejects thimerosal-autism link

Jan 14 (Reuters) - Drugmaker Wyeth (WYE.N: Quote, Profile, Research, Stock Buzz) said a court in Maryland has granted the company's motion to exclude some expert witnesses from testifying that exposure to thimerosal-containing vaccines can cause autism and rejected the compound's link to autism.

In the alleged vaccine injury case, a judge has found that thimerosal in vaccines does not cause or contribute to neurodevelopmental disorders such as autism, the company said in a statement.

Thimerosal is a mercury-containing organic compound, used as a preservative in a number of biological and drug products.

(Reporting by Varsha Tickoo in Bangalore; Editing by Gopakumar Warrier)

((varsha.tickoo@reuters.com; within U.S. +1 646 223 8780; outside U.S. +91 80 4135 5800; Reuters Messaging: varsha.tickoo.reuters.com@reuters.net)) Keywords: WYETH/COURT

(C) Reuters 2008. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWNAS6379